Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;55(7):e70008.
doi: 10.1111/eci.70008. Epub 2025 Feb 10.

Impact of heart failure medications on cognitive function: A systematic review

Soodeh Jahangiri  1 , Eliot Kazakov  2 , Saipranusha Amancherla  2 , Andreas P Kalogeropoulos  3
Affiliations

Impact of heart failure medications on cognitive function: A systematic review

Soodeh Jahangiri et al. Eur J Clin Invest. 2025 Jul.

Abstract

Background: Heart failure (HF) often coexists with cognitive impairment and accelerates cognitive decline. However, the impact of HF medications on cognition has received limited attention. This review evaluates the evidence on the cognitive effects of currently recommended medication classes for HF.

Methods: Systematic review using PubMed and EMBASE following PRISMA guidelines, employing keywords related to HF, cognitive function and guideline-recommended HF medications. Eligible studies were randomized controlled trials (RCT) or cohort studies assessing cognitive function in adult HF patients.

Results: Three cohort studies on ACEi/ARBs (N = 5080; 2 prospective, 1 retrospective) reported no significant impact on cognitive function to higher cognitive scores with ACEi/ARBs. Eight studies on sacubitril/valsartan (ARNI, N = 42,143; all observational studies or post-hoc analyses of RCT) found either no effect on cognitive function or reduced risk of new-onset dementia and improved cognitive outcomes with ARNI. Beta-blockers (N = 40; 1 RCT) lacked significant cognitive effects; empagliflozin (SGLT2i, N = 162; 1 prospective) improved cognitive performance in patients with diabetes and HF with preserved ejection fraction; digoxin (N = 1172; 1 retrospective) was associated with enhanced cognitive function; and statins (N = 112,357; 2 retrospective), which are indicated in HF of ischemic aetiology, were not associated with a significant effect on cognition.

Conclusions: Guideline-recommended HF medication classes appear to have neutral effects on cognitive function, and some may even offer cognitive benefits. However, the limited number and mostly observational nature of studies prevent firm conclusions. Further research is necessary to better understand the cognitive impact of HF medications.

Keywords: ACE inhibitors; angiotensin receptor blockers; cognitive impairment; dementia; heart failure medications; sacubitril/valsartan.

PubMed Disclaimer

References

REFERENCES

    1. Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21:717‐734. doi:10.1038/s41569-024-01046-6
    1. Bozkurt B, Ahmad T, Alexander KM, et al. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail. 2023;29:1412‐1451. doi:10.1016/j.cardfail.2023.07.006
    1. Yohannes AM, Chen W, Moga AM, Leroi I, Connolly MJ. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta‐analysis of observational studies. J Am Med Dir Assoc. 2017;18:451. doi:10.1016/j.jamda.2017.01.014
    1. Adelborg K, Horvath‐Puho E, Ording A, Pedersen L, Sorensen HT, Henderson VW. Heart failure and risk of dementia: a Danish nationwide population‐based cohort study. Eur J Heart Fail. 2017;19:253‐260. doi:10.1002/ejhf.631
    1. Hammond CA, Blades NJ, Chaudhry SI, et al. Long‐term cognitive decline after newly diagnosed heart failure: longitudinal analysis in the CHS (cardiovascular health study). Circ Heart Fail. 2018;11:e004476. doi:10.1161/CIRCHEARTFAILURE.117.004476

Publication types

MeSH terms